REPOITIN 4000 IU INJECTION

Repoltin 4000IU injection contains active components, such as Recombinant human EPO/EPO and erythropoietin Alfa. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). This medication helps treat anemia due to chronic kidney diseases (CKD), cancer chemotherapy, or HIV treatment with zidovudine. It also decreases the need for transfusions of red blood cells for patients at risk of losing blood because of planned surgery and other surgical procedures.
Repoltin 4000IU injections are not recommended for patients who have hypersensitivity towards it or its constituents, uncontrolled hypertension, active thrombotic microangiopathy (TMA) or purified red cell aplasia (PRCA), uncontrolled seizures and pregnancy or lactation. It is also recommended to use it carefully in patients with a background of bleeding clots, heart disease, kidney disease, stroke, body thalassemia, liver diseases, sickle-cell anemia, myelodysplastic disorder, leukemia or cancer. It should not be used for children younger than 18 years old in cases where the benefits are more significant than the risks. Seniors using this medication should be watched closely for adverse consequences. Before beginning this medication, it is crucial to speak with your physician regarding the potential risks and advantages associated with Repoltln 4000 Iu Injection .